A detailed history of Pnc Financial Services Group, Inc. transactions in Nkarta, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 260 shares of NKTX stock, worth $621. This represents 0.0% of its overall portfolio holdings.

Number of Shares
260
Previous 260 -0.0%
Holding current value
$621
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$5.27 - $10.82 $274 - $562
-52 Reduced 16.67%
260 $1,000
Q1 2024

May 10, 2024

BUY
$5.59 - $15.71 $83 - $235
15 Added 5.05%
312 $3,000
Q4 2023

Feb 09, 2024

BUY
$1.31 - $6.6 $389 - $1,960
297 New
297 $1,000
Q4 2021

Feb 11, 2022

SELL
$12.79 - $26.88 $68,042 - $143,001
-5,320 Closed
0 $0
Q2 2021

Aug 06, 2021

BUY
$23.94 - $36.68 $10,054 - $15,405
420 Added 8.57%
5,320 $168,000
Q1 2021

May 07, 2021

BUY
$31.33 - $59.61 $153,517 - $292,089
4,900 New
4,900 $161,000

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $116M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.